Virtus Advisers LLC bought a new stake in shares of Versigent (NYSE:VGNT – Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 17,359 shares of the company’s stock, valued at approximately $780,000.
Several other hedge funds and other institutional investors have also bought and sold shares of VGNT. Fortitude Family Office LLC increased its holdings in shares of Versigent by 497.1% in the 3rd quarter. Fortitude Family Office LLC now owns 621 shares of the company’s stock valued at $28,000 after acquiring an additional 517 shares during the period. Salomon & Ludwin LLC lifted its stake in shares of Versigent by 78.3% during the 3rd quarter. Salomon & Ludwin LLC now owns 708 shares of the company’s stock worth $32,000 after purchasing an additional 311 shares during the last quarter. Jacobi Capital Management LLC purchased a new stake in shares of Versigent during the 3rd quarter worth $38,000. Farther Finance Advisors LLC boosted its position in Versigent by 53.1% during the third quarter. Farther Finance Advisors LLC now owns 1,052 shares of the company’s stock valued at $47,000 after purchasing an additional 365 shares in the last quarter. Finally, Signaturefd LLC boosted its position in Versigent by 40.0% during the third quarter. Signaturefd LLC now owns 1,121 shares of the company’s stock valued at $50,000 after purchasing an additional 320 shares in the last quarter.
Insider Transactions at Versigent
In other Versigent news, Director Kevin Clark sold 74,130 shares of the stock in a transaction dated Wednesday, September 9th. The stock was sold at an average price of $45.67, for a total value of $3,385,517.10. Following the completion of the sale, the director directly owned 124,849 shares in the company, valued at approximately $5,701,853.83. This trade represents a 37.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Over the last quarter, insiders sold 220,000 shares of company stock worth $10,065,848.
Wall Street Analysts Forecast Growth
Several equities analysts have issued reports on the company. Royal Bank Of Canada cut their target price on Versigent from $53.00 to $52.00 and set an “outperform” rating on the stock in a research note on Thursday, November 5th. BNP Paribas Exane reissued an “outperform” rating and set a $54.00 price target (down from $55.00) on shares of Versigent in a research report on Thursday, November 5th. Deutsche Bank reissued a “buy” rating and set a $54.00 price target on shares of Versigent in a research report on Wednesday, August 5th. TD Cowen raised their price target on shares of Versigent from $58.00 to $59.00 and gave the company a “buy” rating in a report on Thursday, November 5th. Finally, Evercore reaffirmed an “outperform” rating and issued a $65.00 price objective on shares of Versigent in a research report on Monday, August 10th. Eleven analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $55.08.
Check Out Our Latest Analysis on VGNT
Versigent Stock Down 0.8%
Shares of VGNT stock traded down $0.34 during trading hours on Friday, reaching $42.12. 449,859 shares of the company’s stock were exchanged, compared to its average volume of 865,765. The stock’s 50 day moving average is $44.26 and its 200-day moving average is $42.67. The company has a market cap of $2.98 billion and a price-to-earnings ratio of 11.00. The company has a current ratio of 1.43, a quick ratio of 1.11 and a debt-to-equity ratio of 5.69. Versigent has a fifty-two week low of $26.34 and a fifty-two week high of $50.88.
Versigent (NYSE:VGNT – Get Free Report) last issued its quarterly earnings data on Wednesday, November 4th. The company reported $1.91 EPS for the quarter, beating the consensus estimate of $1.79 by $0.12. The firm had revenue of $2.45 billion during the quarter, compared to analyst estimates of $2.42 billion. Versigent had a return on equity of 88.25% and a net margin of 5.47%. Analysts predict that Versigent will post 7.37 earnings per share for the current fiscal year.
Versigent Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 17th. Investors of record on Friday, December 4th will be given a dividend of $0.13 per share. This represents a $0.52 annualized dividend and a yield of 1.2%. The ex-dividend date of this dividend is Friday, December 4th.
Versigent Profile
Versigent PLC is involved in the design, manufacturing and delivery of low and high voltage power electrical architectures. Versigent PLC is based in SCHAFFHAUSEN, Switzerland.
Featured Articles
- Five stocks we like better than Versigent
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding VGNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Versigent (NYSE:VGNT – Free Report).
Receive News & Ratings for Versigent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Versigent and related companies with MarketBeat.com's FREE daily email newsletter.
